Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 380-390, February 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ortwerth, B. J.
Right arrow Articles by Novelli, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortwerth, B. J.
Right arrow Articles by Novelli, G. D.

Studies on the Incorporation of L-Ethionine-ethyl-1-14C into the Transfer RNA of Rat Liver1

B. J. Ortwerth and G. David Novelli

Biology Division, NCI-AEC Carcinogenesis Program, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830

When rats were injected with two 50-µc doses of L-ethionine-ethyl-1-14C 24 hours apart, the mixed transfer RNA (tRNA) fraction was labeled to the extent of 200 cpm/A260, but the radioactivity remaining after treatment of the DNA to remove RNA and protein was not significant. Ribosomal RNA, isolated by methylated albumin-kieselguhr chromatography, showed only 5 cpm/A260.

The labeling of tRNA increased linearly from 1 to 12 hours following a single injection of L-ethionine-ethyl-1-14C, reached a maximum at 24 hours, and decayed with an apparent half-life of 2.5 days. When the labeling of tRNA was determined for several rat tissues, the liver tRNA was highest in both specific and total radioactivity.

The ethylation of tRNA by L-ethionine-ethyl-1-14C does not appear to proceed in a manner similar to normal methylation because S-adenosylethionine does not seem to be the active intermediate. This is suggested by the following results:

(a) The S-adenosylethionine content of the liver is the same or greater at 24 hours, when no tRNA ethylation can be seen, than it is at 3 hours, when tRNA ethylation is proceeding at a maximum rate.
(b) An in vitro system which functions well for the methylation of tRNA with S-adenosylmethionine does not ethylate tRNA with S-adenosylethionine.
(c) The presence of a 10-fold excess of methionine-12C increases the labeling of tRNA by L-ethionine-ethyl-1-14C even though it has been reported to inhibit the formation of S-adenosylethionine.
Also, levels of methionine-12C which prevent the formation of S-adenosylethionine completely, do not completely inhibit the ethylation of tRNA.
(d) The distribution of radioactivity across an RPC 2 chromatogram of tRNA labeled with ethionine-ethyl-1-14C is markedly different from that labeled with methionine-methyl-14C.

1 Research jointly sponsored by the National Cancer Institute and by the U. S. Atomic Energy Commission under contract with the Union Carbide Corporation.

Received 10/23/67. Accepted 9/13/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.